👂 Antibiotic Eye Drop Treatment Simulator

Bacterial Conjunctivitis Diagnosed

Placeholder: red eye with sticky purulent discharge signals bacterial cause.

• S. aureus, H. influenzae: Typical pathogens (placeholder text)
• ~10–14 days: Untreated duration (placeholder text)
• Purulent, sticky: Discharge type (placeholder text)
• While discharging: Contagious period (placeholder text)

Recognizing bacterial conjunctivitis

Placeholder: purulent discharge, crusting, and unilateral onset differ from viral or allergic causes.

Why bacterial load matters

Placeholder: bacterial density on the conjunctiva drives inflammation and discharge volume.

Antibiotic Eye Drops Started

Placeholder: topical antibiotic drops begin at a chosen dosing frequency.

• Fluoroquinolones: Common agents (placeholder text)
• 4–6×/day: Typical frequency (placeholder text)
• 5–7 days: Course length (placeholder text)
• 1–2 days: Onset of effect (placeholder text)

Dosing frequency matters

Placeholder: more frequent dosing keeps drug levels above the killing threshold.

Administering drops correctly

Placeholder: proper technique avoids contamination and improves drug contact time.

Bacterial Load Declines Over the Course

Placeholder: repeated dosing steadily reduces bacterial density on the eye surface.

• Dose frequency: Decline driver (placeholder text)
• Faster at high freq: Load half-life (placeholder text)
• Rises if under-dosed: Resistance risk (placeholder text)
• ~Day 3–4: Peak effect day (placeholder text)

Exponential-style clearance

Placeholder: each dose knocks load down further, compounding across the day.

Why missed doses slow clearance

Placeholder: gaps let bacteria rebound between applications.

Discharge and Redness Fade

Placeholder: symptoms trail bacterial load with a short lag as tissue heals.

• Steadily decreasing: Discharge trend (placeholder text)
• Fading by day 5–6: Redness trend (placeholder text)
• ~1 day behind load: Symptom lag (placeholder text)
• Noticeably by day 4: Comfort improves (placeholder text)

Symptoms lag bacterial clearance

Placeholder: inflammation takes time to resolve after bacteria are suppressed.

Why finishing the course matters

Placeholder: stopping early at symptom relief leaves residual bacteria behind.

Full Course vs Early Discontinuation

Placeholder: completing all 7 days prevents recurrence; stopping early risks rebound.

• Near-complete clearance: Full course outcome (placeholder text)
• Recurrence, resistance: Early stop risk (placeholder text)
• 7 days: Recommended course (placeholder text)
• Days after stopping: Recurrence window (placeholder text)

Completing the course

Placeholder: full-length dosing clears residual bacteria and prevents rebound.

Risk of stopping early

Placeholder: surviving bacteria can multiply again and select for resistance.